Many cancer patients may need a sequential one-two punch of immunotherapies
Treating patients with anti-CTLA4 therapies prior to anti-PD1 treatment may be a promising strategy
Sonia Sharma zeros in on metabolites
Cancer immunotherapies may have a better chance of working if scientists can reintroduce a missing metabolite
When a scientist picks up a camera
Dawid Zyla explores the world’s hidden patterns
Timothy Baffi receives ACS award to study acute myeloid leukemia
New support from the American Cancer Society fuels research into the primary mutations behind many cancer types
LJI launches new global cancer immunology resource
National Cancer Institute support brings cancer researchers together to share key findings
In-Depth: La Jolla Institute takes comprehensive look at COVID-19 immunity
Study compares four vaccines and natural immunity
LJI and Synbal, Inc. partner to develop better COVID-19 models
New mouse models may shed light on the puzzling aspects of SARS-CoV-2 infection
A COVID-fighter’s guide to T cells
New LJI review shows how T cells target more than 1,400 sites on SARS-CoV-2
La Jolla Institute for Immunology opens Center for Clinical Investigation
LA JOLLA – Today, La Jolla Institute for Immunology (LJI) celebrated the opening of the John and Susan Major
The new CEO of the La Jolla Institute for Immunology ascended by lifting others
Erica Ollman Saphire brings together scientific competitors to find new antibody therapeutics for COVID-19.
A new window into autoimmune diseases
LJI scientists uncover coordinated immune cell activity as a driver of systemic lupus erythematosus